• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

brent jones

  1. Eyevance

    Anyone have any thoughts on this company and its product Zerviate. Any idea on salary, targeted payout or benefits?